The two companies also shared next steps in their drug testing regimens. The post Atai, Cybin Give Positive Psychedelic Drug Study Updates appeared first...
Psychedelic stocks are on the rise. Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness...
Source: Andrew Partheniou 09/19/2023 This Canadian firm sold assets, launched an equity raise and filed a clinical trial application for its...
Renowned hedge fund manager and Wall Street mogul Steve Cohen is showing his confidence in the psychedelic sector. Cohen’s hedge The post Cybin Rallies...
Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), closed its United States-only public offering raising approximately $2.25 million. The offering consisted...
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,... The post Glancy Prongay...
Renowned billionaire investor Steve Cohen has purchased almost 19 million shares of Cybin. The post Billionaire Investor Steve Cohen Buys 19 million Shares...
Beckley Waves raises $3.3 million, capital to be used for investing in startups focused on infrastructure and services for psychedelic therapies. The post...
Post-traumatic stress Disorder (PTSD) is a debilitating mental health condition that affects millions of people worldwide. It affects 5% of the US population,...
The global inflation surge and monetary policy tightening by major central banks have all contributed to the market volatility this year. Despite that,...